NerveGen is a pre-commercial stage company founded in Q1 2014, which is developing a biomimetic nerve conduit (BNC) intended initially for peripheral nerve injury. The company operates with an exclusive world-wide license through Brown University. The conduit benefits are the following; an off the shelf scaffold to direct and support nerve regeneration, provide for a tension free repair while eliminating painful neuroma and donor site morbidity.